rs426496

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000486.6(AQP2):​c.501T>C​(p.Ser167Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.783 in 1,608,946 control chromosomes in the GnomAD database, including 498,504 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.71 ( 40074 hom., cov: 31)
Exomes 𝑓: 0.79 ( 458430 hom. )

Consequence

AQP2
NM_000486.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -4.37

Publications

22 publications found
Variant links:
Genes affected
AQP2 (HGNC:634): (aquaporin 2) This gene encodes a water channel protein located in the kidney collecting tubule. It belongs to the MIP/aquaporin family, some members of which are clustered together on chromosome 12q13. Mutations in this gene have been linked to autosomal dominant and recessive forms of nephrogenic diabetes insipidus. [provided by RefSeq, Oct 2008]
AQP5-AS1 (HGNC:55474): (AQP5 and AQP2 antisense RNA 2)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 12-49954295-T-C is Benign according to our data. Variant chr12-49954295-T-C is described in ClinVar as Benign. ClinVar VariationId is 504917.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.37 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.807 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AQP2NM_000486.6 linkc.501T>C p.Ser167Ser synonymous_variant Exon 2 of 4 ENST00000199280.4 NP_000477.1
AQP5-AS1NR_110590.1 linkn.310A>G non_coding_transcript_exon_variant Exon 2 of 3
AQP5-AS1NR_110591.1 linkn.118-2207A>G intron_variant Intron 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AQP2ENST00000199280.4 linkc.501T>C p.Ser167Ser synonymous_variant Exon 2 of 4 1 NM_000486.6 ENSP00000199280.3

Frequencies

GnomAD3 genomes
AF:
0.710
AC:
107887
AN:
151888
Hom.:
40036
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.483
Gnomad AMI
AF:
0.774
Gnomad AMR
AF:
0.819
Gnomad ASJ
AF:
0.730
Gnomad EAS
AF:
0.640
Gnomad SAS
AF:
0.694
Gnomad FIN
AF:
0.844
Gnomad MID
AF:
0.684
Gnomad NFE
AF:
0.808
Gnomad OTH
AF:
0.718
GnomAD2 exomes
AF:
0.766
AC:
188673
AN:
246408
AF XY:
0.765
show subpopulations
Gnomad AFR exome
AF:
0.465
Gnomad AMR exome
AF:
0.875
Gnomad ASJ exome
AF:
0.733
Gnomad EAS exome
AF:
0.627
Gnomad FIN exome
AF:
0.841
Gnomad NFE exome
AF:
0.806
Gnomad OTH exome
AF:
0.772
GnomAD4 exome
AF:
0.790
AC:
1151098
AN:
1456940
Hom.:
458430
Cov.:
68
AF XY:
0.788
AC XY:
570946
AN XY:
724942
show subpopulations
African (AFR)
AF:
0.470
AC:
15734
AN:
33472
American (AMR)
AF:
0.866
AC:
38684
AN:
44676
Ashkenazi Jewish (ASJ)
AF:
0.732
AC:
19117
AN:
26126
East Asian (EAS)
AF:
0.633
AC:
25108
AN:
39696
South Asian (SAS)
AF:
0.698
AC:
60206
AN:
86240
European-Finnish (FIN)
AF:
0.844
AC:
41240
AN:
48872
Middle Eastern (MID)
AF:
0.676
AC:
3897
AN:
5766
European-Non Finnish (NFE)
AF:
0.811
AC:
901374
AN:
1111754
Other (OTH)
AF:
0.758
AC:
45738
AN:
60338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
14954
29909
44863
59818
74772
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20758
41516
62274
83032
103790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.710
AC:
107978
AN:
152006
Hom.:
40074
Cov.:
31
AF XY:
0.713
AC XY:
52979
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.484
AC:
20036
AN:
41426
American (AMR)
AF:
0.819
AC:
12525
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.730
AC:
2533
AN:
3472
East Asian (EAS)
AF:
0.639
AC:
3287
AN:
5142
South Asian (SAS)
AF:
0.694
AC:
3341
AN:
4816
European-Finnish (FIN)
AF:
0.844
AC:
8934
AN:
10586
Middle Eastern (MID)
AF:
0.680
AC:
200
AN:
294
European-Non Finnish (NFE)
AF:
0.808
AC:
54895
AN:
67960
Other (OTH)
AF:
0.722
AC:
1521
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1466
2933
4399
5866
7332
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
814
1628
2442
3256
4070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.771
Hom.:
21725
Bravo
AF:
0.702
Asia WGS
AF:
0.737
AC:
2563
AN:
3478
EpiCase
AF:
0.801
EpiControl
AF:
0.795

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Mar 21, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Ser167Ser in exon 2 of AQP2: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue, is not located within the splice consensus sequence, and has been identified in 88.04% (10065/11432) of Latino chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.bro adinstitute.org; dbSNP rs426496). -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Diabetes insipidus, nephrogenic, autosomal Benign:2
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 09, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nephrogenic diabetes insipidus Benign:1
Nov 18, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.35
DANN
Benign
0.55
PhyloP100
-4.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs426496; hg19: chr12-50348078; COSMIC: COSV52229985; COSMIC: COSV52229985; API